|This Slide: #63 of 87|
Slide #63. Regal Entertainment Group — Hollywood Theaters
Regal Entertainment Group (NASDAQ:RGC)
Regal Entertainment Group (NYSE:RGC), a leading motion picture exhibitor owning and operating the largest theatre circuit in the United States, today announced that it has entered into an agreement to acquire Hollywood Theaters. The purchase price will consist of $191 million in cash, approximately $47 million of assumed lease obligations, comprised of capital leases and financing obligations, and certain working capital. The cash portion of the purchase price includes repayment of approximately $157 million of the sellers' debt and is subject to customary post-closing adjustments.
Regencell Bioscience is a holding company. Through its subsidiaries, Co. is an early-stage bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder, and infectious diseases affecting people's immune system such as COVID.
Open the RGC Page at The Online Investor »
Free RGC Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Hold (2.17 out of 4)
(ranked higher than approx. 75% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite